Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 44,837 shares at $66.00 ($2.9M) on 2012-07-27, disclosed to the SEC on 2012-07-30.
Scheduled sale ($2.9M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.00 | 43,299 | $2.8M | 96.5% |
| 2 | $66.00 | 1,538 | $102K | 3.5% |
| Total | $65.03 avg | 44,837 | $2.9M | 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |